ZEEL forms Dragonfly Doji candle on weekly scale
ZEEL forms Dragonfly Doji candle on weekly scale

ZEEL forms Dragonfly Doji candle on weekly scale

Vinayak Gangule Article rating: 3.8

The stock had formed a Dragonfly Doji candle on the weekly scale. The Dragonfly Doji is typically interpreted as a bullish reversal candlestick pattern that mainly occurs at the bottom of downtrends.

When should you consider revisiting your financial plan?
When should you consider revisiting your financial plan?

When should you consider revisiting your financial plan?

DSIJ Intelligence Article rating: 4.0

Financial plan is one of the most important documents that everyone must draw up. However, at times there is a need to revisit your financial plan. Here is when you should consider revisiting it...

Markets end volatile week on a positive note before exit poll outcome
Markets end volatile week on a positive note before exit poll outcome

Markets end volatile week on a positive note before exit poll outcome

Pratik Shastri Article rating: 5.0

Indian benchmarks today ended on a positive note before the outcome of exit polls of Lok Sabha elections. The final poll verdict will be out on May 23, 2019. On a weekly basis, the benchmarks clocked the best week in nearly two months.

Indian Hotels enters into strategic partnership with GSIC
Indian Hotels enters into strategic partnership with GSIC

Indian Hotels enters into strategic partnership with GSIC

Pratik Shastri Article rating: 5.0

Mumbai-based hotel and resorts operator, Indian Hotels Company Ltd, has entered into a strategic partnership with Government of Singapore Investment Corporation (GSIC), on Friday.

Shilpa Medicare surges on receipt of USFDA approval
Shilpa Medicare surges on receipt of USFDA approval

Shilpa Medicare surges on receipt of USFDA approval

Pratik Shastri Article rating: 5.0

Shilpa Medicare informed in a press release that it has received approval from the US regulator for its ANDA, Docetaxel injection on Friday. The stock reacted positively and touched intra-day high of Rs 386 on the BSE.

Lupin: What after Q4FY19 results?
Lupin: What after Q4FY19 results?

Lupin: What after Q4FY19 results?

DSIJ Intelligence Article rating: 5.0

Lupin, one of the largest pharmaceutical companies in India, posted a decent set of numbers for its fourth quarter of FY19. What should you do now?

Aurobindo Pharma falls after regulatory concerns
Aurobindo Pharma falls after regulatory concerns

Aurobindo Pharma falls after regulatory concerns

Pratik Shastri Article rating: 3.0

The Hyderabad-based pharma major Aurobindo Pharma announced on Friday that it has received letters from the USFDA regarding inspections carried out earlier at the company’s API facilities.

RSS
First32713272327332743276327832793280Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR